Oragenics, Inc. / Fundamentals

    Income statement

    Net revenue
    €2.69M
    Cost of goods sold
    €1.35M
    Gross profit
    €0.00
    SG&A expenses
    €5.32M
    R&D expenses
    €2.86M
    EBITDA
    -€8.17M
    D&A
    €1.73M
    EBIT
    -€8.18M
    Interest expenses
    €679.86K
    EBT
    -€8.84M
    Tax expenses
    €0.00
    Net income
    -€8.84M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €155.52K
    Changes in working capital
    €1.40M
    Operating cash flow
    -€6.36M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €5.59M
    Debt repayment
    -€326.39K
    Other financing cash flow
    €1.63M
    Net financing cash flow
    €6.90M
    Foreign exchange effects
    €0.00
    Net change in cash
    €536.36K
    Cash at end of period
    €1.69M
    Free cash flow
    -€6.36M

    Balance sheet

    Cash and cash equivalents
    €1.69M
    Cash and short-term investments
    €1.69M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €142.40K
    Total current assets
    €1.84M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €0.00
    Total assets
    €1.84M
    Accounts payable
    €1.09M
    Short-term debt
    €2.57M
    Other current liabilities
    -€1.09M
    Total current liabilities
    €2.57M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €1.09M
    Total non-current liabilities
    €1.09M
    Total liabilities
    €3.66M
    Common stock
    €706.13
    Retained earnings
    -€189.85M
    Other equity
    €0.00
    Total equity
    -€1.83M
    Total liabilities and shareholders' equity
    €1.84M

    Company information

    Market capitalization
    €2.47M
    Employees
    3
    Enterprise Value
    €2.66M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    -303.3% Much worse than peer group: 256,269.8%
    EBIT margin
    -303.6% Much worse than peer group: 256,422.4%
    EBT margin
    -328.1% Much worse than peer group: 255,212.3%
    Net margin
    -328.1% Much worse than peer group: 283,057.9%
    ROE
    484.1% Much better than peer group: -171.3%
    ROA
    -481.4% Much worse than peer group: -229.0%
    Asset turnover
    146.7% Much better than peer group: 14.2%
    FCF margin
    -236.1% Much worse than peer group: 243,849.9%
    FCF yield
    -257.3%
    Efficiency ratio
    403.3%
    Net sales per employee
    €898.04K
    Net income per employee
    -€2.95M

    Notifications